Related Experiment Video
Updated: Jul 11, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Subarachnoid hemorrhage after thrombolytic therapy for acute myocardial infarction: a case report
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Intracranial hemorrhage is the most feared complication of thrombolytic therapy. This report describes a 42-year-old diabetic woman who presented with an acute myocardial infarction and suffered a subarachnoid hemorrhage after receiving recombinant tissue plasminogen activator. This report discusses this important but very rare complication of thrombolytic therapy.
Intracranial hemorrhage is the most feared complication of thrombolytic therapy. This report describes a 42-year-old diabetic woman who presented with an acute myocardial infarction and suffered a subarachnoid hemorrhage after receiving recombinant tissue plasminogen activator. This report discusses this important but very rare complication of thrombolytic therapy.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
